Afuco™ Anti-Human C5 ADCC Therapeutic Antibody (IFX-1), ADCC Enhanced
Anti-C5 ADCC Enhanced Antibody (IFX-1) is an ADCC enhanced antibody produced by our Afuco™ platform. IFX-1 is a first-in-class new monoclonal antibody which was designed to control a key mechanism driving inflammation.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-080CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | C5 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |